Description

BUY MMBC POWDER ONLINE

MMBC Powder Molar mass of the substance: 383 g/mol Purity of the preparation: 99% Full chemical name: 1-dioxol-yl-3-dimethylamino-butan-2-one Welcome to contact for detail and cooperation

IUPAC name[hide]
Methyl (2S)-2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate
CAS Number 832231-92-2
ChemSpider 34450863
Chemical and physical data
Formula C23H32N2O3
Molar mass 384.52 g·mol−1

2.  History

MDMB-CHMICA (also incorrectly known as MMB-CHMINACA) is an indole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.

While MDMB-CHMICA was initially sold under the name “MMB-CHMINACA”, the compound corresponding to this code name (i.e. the isopropyl instead of t-butyl analogue of MDMB-CHMINACA) has been identified on the designer drug market in 2015 as AMB-CHMINACA.

Several commercial samples of MDMB-CHMICA were found to exclusively contain the (S)-enantiomer based on vibrational and electronic circular dichroism spectroscopy and X-ray crystallography.[7] An (S)-configuration for the tert-leucinate group is unsurprising since MDMB-CHMICA is likely synthesized from the abundant and inexpensive “L” form of the appropriate tert-leucinate reactant.

Product Name: MMBC Molar mass of the substance: 383 g/mol Purity of the preparation: 99% Full chemical name: 1-dioxol-yl-3-dimethylamino-butan-2-one Welcome to contact for detail and cooperation

IUPAC name[hide]
Methyl (2S)-2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate
CAS Number 832231-92-2
ChemSpider 34450863
Chemical and physical data
Formula C23H32N2O3
Molar mass 384.52 g·mol−1

2.  History

MDMB-CHMICA (also incorrectly known as MMB-CHMINACA) is an indole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.

While MDMB-CHMICA was initially sold under the name “MMB-CHMINACA”, the compound corresponding to this code name (i.e. the isopropyl instead of t-butyl analogue of MDMB-CHMINACA) has been identified on the designer drug market in 2015 as AMB-CHMINACA.

Several commercial samples of MDMB-CHMICA were found to exclusively contain the (S)-enantiomer based on vibrational and electronic circular dichroism spectroscopy and X-ray crystallography.[7] An (S)-configuration for the tert-leucinate group is unsurprising since MDMB-CHMICA is likely synthesized from the abundant and inexpensive “L” form of the appropriate tert-leucinate reactant.

.            .